Mutagenesis and cardiovascular diseases Molecular mechanisms, risk factors, and protective factors

被引:50
|
作者
De Flora, Silvio [1 ]
Izzotti, Alberto [1 ]
机构
[1] Univ Genoa, Dept Hlth Sci, I-16132 Genoa, Italy
关键词
atherosclerosis; mutation; DNA adducts; oxidative DNA damage; genetic polymorphisms; prevention;
D O I
10.1016/j.mrfmmm.2006.12.008
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Although no generalization can be made, it is of interest that cancer, cardiovascular diseases, and other chronic conditions often share common risk factors and common protective factors as well as common pathogenetic determinants, such as DNA damage, oxidative stress, and chronic inflammation. Atherosclerosis is the most important cause of vascular forms representing the major cause of death in the population of many geographical areas. A great deal of studies support the "response-to-injury" theory. A variety of experimental and epidemiological findings are also in favor of the somatic mutation theory, which maintains that the earliest event in the atherogenic process is represented by mutations in arterial smooth muscle cells, akin to formation of a benign tumor. These two theories can be harmonized, also taking into account the highly diversified nature of atherosclerotic lesions. Molecular epidemiology studies performed in our laboratory and other laboratories have shown that DNA adducts are systematically present in arterial smooth muscle cells, and their levels are correlated with atherogenic risk factors known from traditional epidemiology. Oxidative DNA damage was also consistently detected in these cells. The role of glutathione S-transferase polymorphisms on the frequency of the above molecular alterations and of arterial diseases is rather controversial. Prevention of both cancer and atherosclerosis is based on avoidance of exposure to risk factors and on fortification of the host defense mechanisms by means of dietary principles and chemopreventive drugs. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:5 / 17
页数:13
相关论文
共 50 条
  • [1] Haemostatic risk factors for cardiovascular diseases
    Koenig, W
    [J]. EUROPEAN HEART JOURNAL, 1998, 19 : C39 - C43
  • [2] RISK FACTORS OF CARDIOVASCULAR DISEASES IN BEIJING
    Yao Chong-hua
    Wu Zhao-su
    Hong Zhao-guang
    Xu Xiao-ming
    Zhang Min
    Wu Yan-yuan
    Yu Shu-e
    Wu Ying-kai
    [J]. CHINESE MEDICAL JOURNAL, 1988, (12)
  • [3] Review of risk factors for cardiovascular diseases
    Wu, LL
    [J]. ANNALS OF CLINICAL AND LABORATORY SCIENCE, 1999, 29 (02): : 127 - 133
  • [4] Cardiovascular diseases and risk factors in Finland
    Vartiainen, E
    Puska, P
    Jousilahti, P
    Korhonen, HJ
    [J]. PREVENTIVE MEDICINE, 1999, 29 (06) : S124 - S129
  • [5] Occupational factors and a risk of cardiovascular diseases
    Strizhakov, L. A.
    Lebedeva, M. V.
    Fomin, V. V.
    Mukhin, N. A.
    [J]. TERAPEVTICHESKII ARKHIV, 2016, 88 (09): : 125 - 130
  • [6] Protective effects and molecular mechanisms of tea polyphenols on cardiovascular diseases
    Guo, Jun
    Li, Kai
    Lin, Yajun
    Liu, Yinghua
    [J]. FRONTIERS IN NUTRITION, 2023, 10
  • [7] Are Traditional Risk Factors for Cardiovascular Diseases Also Risk Factors for Microvascular Disease?
    Reiner, Zeljko
    [J]. CARDIOLOGY, 2024,
  • [8] Molecular Aspects of Cardiovascular Risk Factors
    Xu, Shang-Zhong
    Sathyapalan, Thozhukat
    [J]. BIOMOLECULES, 2024, 14 (08)
  • [9] Risk Factors and Preventive Measures for Cardiovascular Diseases
    Preisner, Katharina
    Hetjens, Svetlana
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (11)
  • [10] Risk factors for cardiovascular diseases in Rheumatoid Arthritis
    Ravindran, V.
    Allen, F.
    Burden, M.
    Carr, M.
    Hughes, R.
    [J]. RHEUMATOLOGY, 2006, 45 : I117 - I118